JPRN-UMIN000019347已完成未知
Evaluation of efficacy and safety in bFGF injection to treat severe vocal fold lesions and vocal fold paralysis. - bFGF injection for vocal fold lesions.
Tokyo Voice Center, International University of Health and Welfare0 个研究点目标入组 12 人开始时间: 2015年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
Results: No adverse events were recorded. Significant improvements were observed in the maximum phonation time (MPT) and Voice Handicap Index (VHI) after treatment. Multiple injections achieved additional effects. Conclusions and significance: bFGF injection may be a safe and suitable office-based surgery for the alleviation of hoarseness caused by SV based on this preliminary short-term study.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •The subjects with obvious decrease in cardiac function, respiratory function, or hepatic dysfunction in preoperative examinations such as blood sampling, electrocardiogram, or chest x-ray within 3 months. The subjects with vital signs such as heart rate, blood oxygen saturation, and blood pressure are abnormal on the day of surgery. The subjects with other laryngeal disease. The subjects with a history of laryngeal cancer The subjects with drug allergy
研究者
相似试验
已完成
不适用
The study of implanting b-FGF applied Terudermis in scarred vocal fold.JPRN-UMIN000003335ihon University Surugadai Hospital20
已完成
不适用
Growth factors augmentation for arthroscopic rotator cuff repairRotator-cuff tendon tearInjury, Occupational Diseases, PoisoningInjury of muscle and tendon at shoulder and upper arm levelISRCTN49643328Ospedale Civile (Italy)82
招募中
不适用
Safety and Efficacy of G-CSF 'filgrastim BS' administration in the peripheral blood stem cell (PBSC) mobilizatioRelated donors for allogeneic PBSC transplantationJPRN-UMIN000015132Div. Hematology and Div. Transfusion Medicine, Kanazawa University Hospital20
暂停
4 期
Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000003105The First People's Hospital of Jiangxia District, Wuhan
已完成
4 期
Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OAJoint DiseaseNCT00782197Biotechnology Institute IMASD240
